Study of M2ES With Paclitaxel/Carboplatin (TC Regimen) in Advanced Non Small Cell Lung Cancer (NSCLC)
The purpose of this study is to evaluate safety and tolerance of M2ES with TC regimen in advanced NSCLC.
Non Small Cell Lung Cancer
DRUG: M2ES
Adverse events incidence,including severe adverse events incidence, one year
Tumor response rate and disease controlled rate, one year
The purpose of this study is to evaluate safety and tolerance of M2ES with TC regimen in advanced NSCLC.